https://acuity.news/technology/floreo-vr-autism-therapy-fda-de-novo-review-2026/Acuity Newsen2026-09-11T11:58:00-06:00Floreo’s FDA Decision on Its VR Autism Therapy Lands This Fall. CEO Vijay Ravindran Says the Pivotal Trial’s Most Striking Result Showed Up in the Parents. https://acuity.news/regulation/injectable-buprenorphine-buy-and-bill-addiction-treatment-economics-2026/Acuity Newsen2026-09-11T07:55:26-06:00Addiction Treatment Is Shifting From a Daily Pill to a Monthly Shot, and the Economics Are Shifting With It. Long-Acting Injectables Turn Medication Into a Billable Clinical Service.